AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Ishii, K Tamaoka, A Shoji, S
Citation: K. Ishii et al., A case of primary focal lingual dystonia induced by speaking, EUR J NEUR, 8(5), 2001, pp. 507-507

Authors: Tokuda, T Tamaoka, A Matsuno, S Sakurai, S Shimada, H Morita, H Ikeda, S
Citation: T. Tokuda et al., Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins, ANN NEUROL, 49(4), 2001, pp. 546-547

Authors: Ishii, K Lippa, C Tomiyama, T Miyatake, F Ozawa, K Tamaoka, A Hasegawa, T Fraser, PE Shoji, S Nee, LE Pollen, DA St George-Hyslop, PH Ii, K Ohtake, T Kalaria, RN Rossor, MN Lantos, PL Cairns, NJ Farrer, LA Mori, H
Citation: K. Ishii et al., Distinguishable effects of Presenilin-1 and APP717 mutations on amyloid plaque deposition, NEUROBIOL A, 22(3), 2001, pp. 367-376

Authors: Hoshi, K Yoshida, K Nakamura, A Tada, T Tamaoka, A Ikeda, S
Citation: K. Hoshi et al., Cessation of cerebral hemorrhage recurrence associated with corticosteroidtreatment in a patient with cerebral amyloid angiopathy, AMYLOID, 7(4), 2000, pp. 284-288

Authors: Tamaoka, A Matsuno, S Ono, S Shimizu, N Shoji, S
Citation: A. Tamaoka et al., Increased amyloid beta protein in the skin of patients with amyotrophic lateral sclerosis, J NEUROL, 247(8), 2000, pp. 633-635

Authors: Cavani, S Tamaoka, A Moretti, A Marinelli, L Angelini, G Di Stefano, S Piombo, G Cazzulo, V Matsuno, S Shoji, S Furiya, Y Zaccheo, D Dagna-Bricarelli, F Tabaton, M Mori, H
Citation: S. Cavani et al., Plasma levels of amyloid beta 40 and 42 are independent from ApoE genotypeand mental retardation in Down syndrome, AM J MED G, 95(3), 2000, pp. 224-228

Authors: Harada, H Ohkoshi, N Fujita, Y Tamaoka, A Shoji, S
Citation: H. Harada et al., Clinical improvement following interferon-alpha alone as an initial treatment in CIDP, MUSCLE NERV, 23(2), 2000, pp. 295-296

Authors: Mochizuki, A Tamaoka, A Shimohata, A Komatsuzaki, Y Shoji, S
Citation: A. Mochizuki et al., A beta 42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease, LANCET, 355(9197), 2000, pp. 42-43

Authors: Tamaoka, A Miyatake, F Matsuno, S Ishii, K Nagase, S Sahara, N Ono, S Mori, H Wakabayashi, K Tsuji, S Takahashi, H Shoji, S
Citation: A. Tamaoka et al., Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease, NEUROLOGY, 54(12), 2000, pp. 2319-2321

Authors: Yasuda, M Maeda, S Kawamata, T Tamaoka, A Yamamoto, Y Kuroda, S Maeda, K Tanaka, C
Citation: M. Yasuda et al., Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy, J NE NE PSY, 68(2), 2000, pp. 220-223

Authors: Tamaoka, A Sekijima, Y Masuno, S Tokuda, T Shoji, S Ikeda, SI
Citation: A. Tamaoka et al., Amyloid beta protein species in cerebrospinal fluid and in brain from patients with Down's syndrome, ANN NEUROL, 46(6), 1999, pp. 933-933

Authors: Hu, J Miyatake, F Aizu, Y Nakagawa, H Nakamura, S Tamaoka, A Takahash, R Urakami, K Shoji, M
Citation: J. Hu et al., Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population, NEUROSCI L, 277(1), 1999, pp. 65-67

Authors: Hoshino, S Hayashi, A Tamaoka, A Shoji, S
Citation: S. Hoshino et al., Bilateral gustatory disturbance caused by a unilateral pontine lesion, NEUROLOGY, 53(5), 1999, pp. 1160-1160

Authors: Hoshino, S Yoshizawa, T Hayashi, A Ohkoshi, N Tamaoka, A Shoji, S
Citation: S. Hoshino et al., A combination of autoimmune hepatitis, sensory-dominant peripheral neuropathy, and primary Sjogren's syndrome in the same patient: A rare association, J MED, 30(1-2), 1999, pp. 83-92

Authors: Harada, H Tamaoka, A Kohno, Y Mochizuki, A Shoji, S
Citation: H. Harada et al., Exacerbation of myasthenia gravis in a patient after interferon-beta treatment for chronic active hepatitis C, J NEUR SCI, 165(2), 1999, pp. 182-183

Authors: Christie, G Markwell, RE Gray, CW Smith, L Godfrey, F Mansfield, F Wadsworth, H King, R McLaughlin, M Cooper, DG Ward, RV Howlett, DR Hartmann, T Lichtenthaler, SF Beyreuther, K Underwood, J Gribble, SK Cappai, R Masters, CL Tamaoka, A Gardner, RL Rivett, AJ Karran, EH Allsop, D
Citation: G. Christie et al., Alzheimer's disease: Correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome, J NEUROCHEM, 73(1), 1999, pp. 195-204
Risultati: 1-16 |